 Pharmacodynamics cancer therapy understanding anticancer pharmacodynamics relationships pharmacologic measurements clinical effects recent years due advances analytical computational technology methotrexate plasma levels leucovorin high-dose methotrexate therapy standard use therapeutic drug monitoring oncology investigators dose antineoplastic agents models real-time analysis plasma drug tissue concentrations Studies progress hexamethylene bisacetamide fluorouracil FUra cytarabine ara-C Future studies optimal sampling strategies analysis intermediate biochemical end points combination chemotherapy modulation colony-stimulating factors sophisticated pharmacodynamic models